A novel JAK inhibitor JTE‐052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0625|27|1|22-29

ISSN： 0906-6705

Source： EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol.27, Iss.1, 2018-01, pp. : 22-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of topical JTE‐052, a Janus kinase inhibitor, in Japanese adult patients with moderate‐to‐severe atopic dermatitis: a phase II, multicentre randomized, vehicle‐controlled clinical study

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : e169-e169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of topical JTE‐052, a Janus kinase inhibitor, in Japanese adult patients with moderate‐to‐severe atopic dermatitis: a phase II, multicentre, randomized, vehicle‐controlled clinical study

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 424-432

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Novel Inhibitor Of Inflammatory Cytokine Production (CNI-1493) Reduces Rodent Post-Hemorrhagic Vasospasm

By  

Neurocritical Care, Vol. 5, Iss. 3, 2006-12 ,pp. : 222-229

Humana Press, Inc

Access to resources Recommend Favorite

Novel Antioxidant Ameliorates the Fibrosis and Inflammation of Cerulein-Induced Chronic Pancreatitis in a Mouse Model

By  

Pancreatology, Vol. 5, Iss. 2-3, 2005-05 ,pp. : 165-176

Karger

Access to resources Recommend Favorite

Leukocytes and Skin Disease: Conflicting Patterns of Inflammation in Atopic Dermatitis and Psoriasis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 13, Iss. 6, 1986-12 ,pp. : 408-416

John Wiley & Sons Inc

Access to resources Recommend Favorite